Furthermore, accumulating clinical evidence has demonstrated that circulating adiponectin levels are not only associated with the onset of CAD but are also independently associated with cardiovascular mortality [18, 20–23]. The gene discussed is ADIPOQ; the disease is coronary artery disorder.